🎁 Black Friday: up to 50% off of annual plans
WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
70.50
-0.30 (-0.42%)
Nov 20, 2026, 1:24 PM CST

WeLeader Biomedical Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
263.85208.56170.21152.28153.8105.77
Depreciation & Amortization
141.76124.16108.58103.8109.82114.44
Loss (Gain) From Sale of Assets
0.31-0.021.69-0.69-0.41
Loss (Gain) From Sale of Investments
-5.18-0.15-0.4-0.10.68-0.01
Stock-Based Compensation
-1.61-0.184.233.65
Provision & Write-off of Bad Debts
0.03-0.10.06-0.48-0.530.39
Other Operating Activities
15.58-0.59-6.84-19.568.4112.49
Change in Accounts Receivable
-69.51-46.63-5.75-3.1721.59-47.61
Change in Inventory
2.39-18.78-29.81-5.77-7.1-13.37
Change in Accounts Payable
3.2920.3940.35-12.09-5.3743.39
Change in Unearned Revenue
0.373.671.19-0.36-1.251.02
Change in Other Net Operating Assets
23.8421.161.1415.43-3.318.27
Operating Cash Flow
377.41313.3278.76231.86280.27238.03
Operating Cash Flow Growth
51.17%12.39%20.23%-17.27%17.75%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-77.6-212.74-170.71-114.73-659.36-21.6
Sale of Property, Plant & Equipment
1.29--0.951.060.42
Sale (Purchase) of Intangibles
-7.41-1.01-3.56-1-2.29-2.3
Investment in Securities
-38.03-61.66-22.390.83-4.6820.77
Investing Cash Flow
-122.03-275.4-196.65-113.96-665.28-2.71

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-807922424753
Long-Term Debt Issued
-625.01193.13-29120
Total Debt Issued
524.22705.01272.1322453873
Short-Term Debt Repaid
--160-56-288.03-178.97-122
Long-Term Debt Repaid
--605.21-122.33-91.64-118.66-154.6
Lease Payments
-107.27-96.02-78.61-72.39-80.63-79.41
Total Debt Repaid
-680.38-765.21-178.33-379.67-297.63-276.6
Net Debt Issued (Repaid)
-156.17-60.2193.8-155.67240.37-203.6
Issuance of Common Stock
0.02238.22-61.48143.64-
Common Dividends Paid
-186.46-153.17-95.63-29.75-9.77-22.36
Other Financing Activities
2.62----0.02-
Financing Cash Flow
-339.9924.85-1.83-123.94374.22-225.96

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-84.662.7480.28-6.03-10.799.35

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
299.81100.56108.06117.13-379.09216.43
Free Cash Flow Growth
550.38%-6.94%-7.75%---
Free Cash Flow Margin
23.68%9.06%10.90%12.45%-36.60%25.73%
Free Cash Flow Per Share
5.862.162.592.85-12.467.70
Levered Free Cash Flow
109.1449.3867.88106.57-412.67-
Unlevered Free Cash Flow
120.5154.3971.51110.13-410.04-
Free Cash Flow After Leases
192.544.5429.4544.74-459.72137.02

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
13.8413.8414.9413.66.426.31
Cash Income Tax Paid
47.1247.1243.151.7428.4411.83
Change in Working Capital
-39.63-20.197.12-5.954.561.7